{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T05:24:17Z","timestamp":1697261057997},"reference-count":23,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2003,1,14]],"date-time":"2003-01-14T00:00:00Z","timestamp":1042502400000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[2003,1]]},"abstract":"<jats:p><jats:bold>Abstract:<\/jats:bold>  <jats:italic>Background<\/jats:italic>: Transmissible spongiform encephalopathies (TSEs) are neuropathological diseases caused by prions. Prions are infectious particles (PrP<jats:sup>Sc<\/jats:sup>) which can induce bovine spongiform encephalopathy and most likely also the related infectious disease, variant of Creutzfeldt\u2010Jakob disease (vCJD). The exposure of humans to orally ingested BSE agent in contaminated meat products presumably led to the emergence of vCJD. In vCJD, prions can be detected immunohistochemically not only in neuronal tissue but also in lymphoreticular tissue. vCJD is of significance in transfusion medicine because of the hypothetical transmission of prions by blood products. <jats:italic>Methods<\/jats:italic>: An immunohistochemistry method was used to allow screening for vCJD in human lymphoreticular tissue. <jats:italic>Results<\/jats:italic>: PrP<jats:sup>Sc<\/jats:sup> can be detected in the cerebrum and cerebellum of patients with sporadic Creutzfeldt\u2010Jakob disease (sCJD) and in the lymph nodes, tonsils, and spleen of vCJD patients. This method has the major advantage of working in fixed specimens which are routinely saved in departments of pathology and therefore allows screening of large numbers of archived human lymphoreticular tissues in different regional areas and from different time points. Scrapie\u2010positive lymphoreticular sheep tissue reacts similarly to human tissue of vCJD affected patients and is available in sufficient amounts to be used as positive control in screening programs. <jats:italic>Conclusion<\/jats:italic>: A method is provided which is a feasible tool for an epidemiological screening program to assess the prevalence of the assumed infectious agent of vCJD, PrP<jats:sup>Sc<\/jats:sup>, in various populations.<\/jats:p>","DOI":"10.1034\/j.1600-0609.2003.02839.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T18:53:45Z","timestamp":1047408825000},"page":"11-16","source":"Crossref","is-referenced-by-count":1,"title":["Role of variant Creutzfeldt\u2010Jakob disease for safety of treatment with blood components: screening of lymphatic tissue is a potential tool for risk assessment"],"prefix":"10.1034","volume":"70","author":[{"given":"C.","family":"Sachse","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. H.","family":"Groschup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Warzok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Greinacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,1,14]]},"reference":[{"key":"e_1_2_16_2_2","first-page":"28","volume-title":"Spongiforme Enzephalopathien bei Tieren Unter Besonderer Ber\u00fccksichtigung der BSE. Schriftenreihe Nova Acta Leopoldina, no. 298: Bd. 75.","author":"Oesch B","year":"1996"},{"key":"e_1_2_16_3_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.6801762"},{"key":"e_1_2_16_4_2","first-page":"535","article-title":"Kuru and \u2018new variant\u2019 CJD","volume":"28","author":"Verdrager J","year":"1997","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"e_1_2_16_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-510X(98)00226-3"},{"key":"e_1_2_16_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/38876"},{"key":"e_1_2_16_7_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.26.15137"},{"key":"e_1_2_16_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.1999.tb14400.x"},{"key":"e_1_2_16_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)12075-5"},{"key":"e_1_2_16_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)24035-9"},{"key":"e_1_2_16_11_2","doi-asserted-by":"publisher","DOI":"10.1053\/jcpa.1999.0343"},{"key":"e_1_2_16_12_2","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/oxfordjournals.bmb.a072650","article-title":"PrP gene and its association with spongiform encephalopathies","volume":"49","author":"Goldmann W","year":"1993","journal-title":"Br Med Bull"},{"key":"e_1_2_16_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-1135(97)00165-X"},{"key":"e_1_2_16_14_2","doi-asserted-by":"publisher","DOI":"10.1053\/tvjl.1999.0406"},{"key":"e_1_2_16_15_2","volume-title":"Introduction to Immunohistochemistry.","author":"Polak JM","year":"1997"},{"key":"e_1_2_16_16_2","unstructured":"ProMED\u2010mail. (International Society for Infectious Diseases).CJD (new var.) \u2013 UK update Oct. UK Department of Health press release 2002\/0412 Mon 7 October 2002 (www.doh.gov.uk\/cjd\/stats\/oct02.htm). In:www.promedmail. org 2002."},{"key":"e_1_2_16_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02559-9"},{"key":"e_1_2_16_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02785-9"},{"key":"e_1_2_16_19_2","unstructured":"ProMED\u2010mail. (International Society for Infectious Diseases).CJD (new var.) \u2013 Incidence & trends. UK.source:Brian Matthews Tue 8 October 2002 (lt09@dial. pipex.com). In:www.promedmail.org 2002."},{"key":"e_1_2_16_20_2","first-page":"1226","article-title":"First results of vCJD survey show no signs of prion","volume":"320","author":"Dobson R","year":"2000","journal-title":"Br Med J"},{"key":"e_1_2_16_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02243-1"},{"key":"e_1_2_16_22_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.325.7365.633"},{"key":"e_1_2_16_23_2","first-page":"833","article-title":"Healthy carriers could increase vCJD risk, scientist say","volume":"356","author":"Bonn D","year":"2000","journal-title":"Lancet"},{"key":"e_1_2_16_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0268-960X(98)90007-8"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-0609.2003.02839.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-0609.2003.02839.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1034\/j.1600-0609.2003.02839.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T19:10:25Z","timestamp":1697224225000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1034\/j.1600-0609.2003.02839.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,1]]}},"alternative-id":["10.1034\/j.1600-0609.2003.02839.x"],"URL":"https:\/\/doi.org\/10.1034\/j.1600-0609.2003.02839.x","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,1]]}}}